Gabapentin and pregabalin exposures reported to United States poison centers, 2012-2022
Abstract Background Gabapentin and pregabalin were originally introduced as anticonvulsant medications but are now also prescribed on- and off-label for multiple medical disorders, especially for pain management. The national opioid crisis has led to increased use of non-opioid pain medications, inc...
Saved in:
Main Authors: | Emily J.R. Carter (Author), Natalie I. Rine (Author), Sandhya Kistamgari (Author), Hannah L. Hays (Author), Henry A. Spiller (Author), Jingzhen Yang (Author), Motao Zhu (Author), Gary A. Smith (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Loperamide cases reported to United States poison centers, 2010-2022
by: Aaditya Patel, et al.
Published: (2023) -
Hydrocarbon ingestions among individuals younger than 20 years old reported to United States Poison Centers, 2000-2021
by: Samiza B. Palmer, et al.
Published: (2023) -
Therapeutic errors involving diabetes medications reported to United States poison centers
by: Ashley Thurgood Giarman, et al.
Published: (2024) -
Gabapentin and Pregabalin in chronic neuropathic pain: cost efficacy evaluation
by: Paolo Marchettini, et al.
Published: (2005) -
Comparison of pregabalin with gabapentin as preemptive analgesic in lumbar spine surgery
by: Sidharth S Routray, et al.
Published: (2018)